Prognosis
Moderna Chief Sells More Shares Ahead of Key Vaccine Filing
- Bancel sold total combined of 19,000 shares starting Nov. 18
- CEO’s net worth has surged past $3.1 billion after share rally
Stephane Bancel
Photographer: Adam Glanzman/BloombergThis article is for subscribers only.
Moderna Inc. chief executive officer Stephane Bancel offloaded another $1.74 million of shares last week while the world awaits for the biotech company to be the second to file its vaccine for emergency use in the U.S.
Stock in Cambridge, Massachusetts based Moderna climbed as much as 4.3% to $101.77 on Monday. The sale comes after Pfizer Inc. and BioNTech SE became the first companies to complete a submission for a vaccine to U.S. regulators on Friday. Moderna is likely to file its vaccine next week, Morgan Stanley analysts said.